NK cells after HSCT express high levels of CD56 27–30, 32, 33. This has often been used as an argument that ptCD56bright are immature 29, 31, 32, 34. Here, we report that ptCD56bright have only few characteristics

of immature NK cells and are indistinguishable from cytokine-activated CD56bright. We show that ptCD56bright are CD11b+CD27−, a phenotype characteristic of mature NK cells and that CD11b+CD27+CD56bright become CD11b+CD27− after stimulation with IL-15. Both PXD101 datasheet ptCD56bright and NKIL-15 were CCR7−, HLA-DR and perforin-positive and readily produced IFN-γ after stimulation with IL-12. We also found that after culture in the absence of cytokines, ptCD56bright and NKIL-15 upregulated c-kit, CD127 but not CCR7. Hence, stimulation with IL-15 induces many of the features characteristic of ptCD56bright on CD56bright and because both cell types also regulated the expression of c-kit, CD127 and CCR7 in a similar manner, we believe that ptCD56bright are mature CD56bright that have expanded after being stimulated by the elevated cytokine levels that have been observed

in the serum of transplanted patients 27–29. The finding that the number of ptCD56bright was not correlated with the level of hematopoiesis supported this hypothesis further. We found that the number of ptCD56bright was highest in patients with low numbers of Talazoparib order T cells. During the first month after transplantation, T cells are generated by peripheral expansion rather than through the hematopoiesis-dependent thymic pathway 44–46. This expansion is driven by IL-7 and IL-15 of which the latter also regulates the homeostasis of NK cells 47, 48. CD8+ memory effector T cells are known to restrict IL-15-dependent homeostasis

of γδ-T cells 49, 50. Furthermore, NK cells and CD8+ T cells compete for IL-15 in lymphopenic mice 51. Therefore, it is conceivable that CD8+ T cells that represent the major T-cell Selleckchem Neratinib population after transplantation also compete with NK cells for the elevated levels of IL-15 present in transplanted patients 27–29. Because IL-15 also induces the ptCD56bright phenotype in CD56bright, we think that IL-15 is most likely to be the cytokine with the most impact on the post-transplant NK-cell compartment. The correlations between the number of NK cells and the plasma levels of IL-15 after HSCT have been reported as absent 29, weak 27 or strong 28. We have not measured IL-15 serum levels in our cohort because we believed that there would be too many reasons why the relationship between IL-15 levels and NK-cell expansion may remain hidden. First, most IL-15 is presented in trans in tissues 52 and could effectively stimulate NK cells also when serum levels are low.